The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
Open accessAbstract
Resveratrol (3,4',5 tri-hydroxystilbene) is a phytoalexin produced in hudge amount in grapevine skin in response to infection by Bothrytis cinerea. This production of resveratrol blocks the proliferation of the pathogen, thereby acting as a natural antibiotic. Numerous studies have reported interesting properties of trans-resveratrol as a preventive agent against important pathologies i.e. vascular diseases, cancers, viral infection or neurodegenerative processes. Moreover, several epidemiological studies have revealed that resveratrol is probably one of the main microcomponents of wine responsible for its health benefits such as prevention of vaso-coronary diseases and cancer. Resveratrol acts on the process of carcinogenesis by affecting the three phases: tumor initiation, promotion and progression phases and suppresses the final steps of carcinogenesis, i.e. angiogenesis and metastasis. It is also able to activate apoptosis, to arrest the cell cycle or to inhibit kinase pathways. Interestingly, resveratrol does not present any cytotoxicity in animal models. Moreover, concentrations of resveratrol in blood seem to be sufficient for anti-invasive activity. The enterohepatic recirculation may contribute to a delayed elimination of the drug from the body and bring about a prolonged effect. By its binding to plasmatic proteins, resveratrol also exhibits a prolonged effect. Interestingly, low doses of resveratrol can sensitize to low doses of cytotoxic drugs and so provide an innovative strategy to enhance the efficacy of anticancer therapy in various human cancers. By these properties, resveratrol appears to be a good candidate in chemopreventive or chemotherapeutic strategies and is believed to be a novel weapon for new therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer chemopreventive activity of resveratrol.
Jang, M., & Pezzuto, J. M. (1999) · PubMed · Cited by 225
Cao, Z., Fang, J., Xia, C., Shi, X., & Jiang, B.-H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0588 · Cited by 173
Plasma and tissue resveratrol concentrations and pharmacological activity.
Bertelli, A., Bertelli, A. A. E., Gozzini, A., & Giovannini, L. (1998) · PubMed · Cited by 169
Cadenas, S., & Barja, G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00019-2 · Cited by 139
Botanical antioxidants for chemoprevention of photocarcinogenesis
Afaq, F., Adhami, V. M., Ahmad, N., & Mukhtar, H. (2002) · Frontiers in bioscience · doi:10.2741/afaq · Cited by 135
Resveratrol Inhibits Cyclooxygenase‐2 Transcription in Human Mammary Epithelial Cells
Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., TELANG, N. T., & Dannenberg, A. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08737.x · Cited by 93
Shih, A., Zhang, S., Cao, H., et al. (2004) · PubMed · Cited by 69
Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes
Yueh, M., Kawahara, M. S., & Raucy, J. L. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.10.003 · Cited by 66
Resveratrol inhibits benzo[a]pyrene–DNA adduct formation in human bronchial epithelial cells
Berge, G., Øvrebø, S., Botnen, I. V., Hewer, A. J., Phillips, D. H., Haugen, A., & Mollerup, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601898 · Cited by 46
Cited by
A critical review of methods for characterisation of polyphenolic compounds in fruits and vegetables
Ignat, I., Volf, I., & Popa, V. I. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2010.12.026 · Cited by 1,469
Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
Wang, R.-H., Sengupta, K., Li, C., Kim, H.-S., Cao, L., Xiao, C., Kim, S., Xu, X., Zheng, Y., Chilton, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.001 · Cited by 769
Resveratrol: A review of preclinical studies for human cancer prevention
ATHAR, M., BACK, J., TANG, X., KIM, K., KOPELOVICH, L., BICKERS, D., & KIM, A. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.025 · Cited by 731
Peanuts as functional food: a review
Arya, S. S., Salve, A. R., & Chauhan, S. (2016) · Journal of Food Science and Technology · doi:10.1007/s13197-015-2007-9 · Cited by 628
Phenolic compounds in fruits – an overview
Haminiuk, C. W. I., Maciel, G. M., Plata‐Oviedo, M. S. V., & Peralta, R. M. (2012) · International Journal of Food Science & Technology · doi:10.1111/j.1365-2621.2012.03067.x · Cited by 566
Almeida, L., Vaz‐da‐Silva, M., Falcão, A., Soares, E., Costa, R., Loureiro, A. I., Fernandes‐Lopes, C., Rocha, J., Nunes, T., Wright, L., et al. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800177 · Cited by 426
Chiba, T., Marusawa, H., & Ushijima, T. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.009 · Cited by 381
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Wang, R.-H., Zheng, Y., Kim, H.-S., Xu, X., Cao, L., Lahusen, T., Lee, M.-H., Xiao, C., Vassilopoulos, A., Chen, W., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.011 · Cited by 359
Phytosterols as anticancer compounds
Bradford, P. G., & Awad, A. B. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600164 · Cited by 351
Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
Chow, H.-H. S., Garland, L. L., Hsu, C.-H., Vining, D. R., Chew, W. M., Miller, J. A., Perloff, M., Crowell, J. A., & Alberts, D. S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0155 · Cited by 330
Phenol‐Based Antioxidants and the In Vitro Methods Used for Their Assessment
Craft, B. D., Kerrihard, A. L., Amarowicz, R., & Pegg, R. B. (2012) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2011.00173.x · Cited by 329
Hasan, N., Nadaf, A., Imran, M., Jiba, U., Sheikh, A., Almalki, W. H., Almujri, S. S., Mohammed, Y. H., Kesharwani, P., & Ahmad, F. J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01854-3 · Cited by 322
Resveratrol addiction: To die or not to die
Shakibaei, M., Harikumar, K. B., & Aggarwal, B. B. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800148 · Cited by 316
Review of Natural Compounds for Potential Skin Cancer Treatment
Chinembiri, T., Du Plessis, L., Gerber, M., Hamman, J., & Du Plessis, J. (2014) · Molecules · doi:10.3390/molecules190811679 · Cited by 270
Baxter, R. A. (2008) · Journal of Cosmetic Dermatology · doi:10.1111/j.1473-2165.2008.00354.x · Cited by 263
Dull, A.-M., Moga, M. A., Dimienescu, O. G., Sechel, G., Burtea, V., & Anastasiu, C. V. (2019) · Molecules · doi:10.3390/molecules24040667 · Cited by 141
Martins, L. A. M., Coelho, B. P., Behr, G., Pettenuzzo, L. F., Souza, I. C. C., Moreira, J. C. F., Borojevic, R., Gottfried, C., & Guma, F. C. R. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9703-8 · Cited by 82
Do, M. H., Lee, S. S., Jung, P. J., & Lee, M. H. (2007) · Nutrition and Cancer · doi:10.1080/01635580701268063 · Cited by 56
Hamburger, T., Broecker-Preuss, M., Hartmann, M., Schade, F. U., de Groot, H., & Petrat, F. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.01.024 · Cited by 28
Courtaut, F., Scagliarini, A., Aires, V., Cornebise, C., Pais de Barros, J.-P., Olmiere, C., & Delmas, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126590 · Cited by 17
Self-citation
Metadata
- Authors
- Delmas, D., Lancon, A., Colin, D., Jannin, B., & Latruffe, N.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2006-04-01
- Volume
- 7
- Issue
- 4
- Pages
- 423-442
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2105423725
- Cited by
- 395
- References
- 9
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.